Qulipta
Chemical Name | atogepant |
Dosage Form | Tablet (oral; 10 mg, 30 mg, 60 mg) |
Drug Class | Calcitonin gene-related peptide receptor antagonists |
System | Nervous |
Company | AbbVie |
Approval Year | 2021 |
Indication
- For the preventive treatment of episodic migraine in adults.